Page History

SYNOPSIS:

The Translational Medicine Mart (tranSMART) is a new, open-source platform for translational research originally based on the NIH-funded Informatics for Integrating Biology and the Bedside (i2b2) initiative.  Key use cases that tranSMART focuses upon include knowledge management for the combination of clinical and molecular data sets for use in ad-hoc analyses; identification of novel biomarkers associated with stratifications of disease or treatment response; and selection of potential indications for novel and known treatments targeting common molecular pathways.  The presentation will include a live demonstration of the current release of the software to highlight key capabilities.

BIO:

Dan Housman is the founder and Chief Technology Officer of Recombinant Data Corporation.  He has worked as a consultant and builds technology to bridge complex gaps and establish new solutions in such areas as collaborating on clinical and genomic data sets across organizational boundaries in academic medical centers, pharmaceutical organizations,  government, and private research initiatives.  Mr. Housman earned a B.S. in chemistry and biology from the Massachusetts Institute of Technology in 1995. He is a member of the Healthcare Data Warehousing Association and the American Medical Informatics Association.  Mr. Housman has developed informatics solutions for Partners Healthcare, the University of Minnesota, and UCLA as well as a number of cancer centers including the Kimmel Cancer Center, Dana Farber, the University of Michigan Cancer Center and City of Hope. 

SUMMARY:

Topic: The Translational Medicine Mart (tranSMART)

Speaker: Dan Housman

Date: Wednesday, October 17, 2012

...